Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin

Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 4

Abstract

Background and aims. Genetic variations in the interleukin 28B (IL28B) gene have been associated with viral response to PEG-interferon-α/ribavirin (PR) therapy in hepatitis C virus (HCV) genotype 1 infected patients from North America, Europe and Asia. The importance of these IL28B variants for Argentine patients remains unknown. Material and methods. IL28B host genotypes (rs8099917 and rs12979860) were determined in a population of Argentine patients with European ancestry. Results were analyzed looking for their association with sustained virologic response (SVR) to PR therapy and compared with other baseline hosts’ biochemical, histological and virological predictors of response. Results. We studied 102 patients, 60% were men, and 40% of them were rs8099917 TT and 18% rs12979860 CC. Mean baseline serum HCV RNA was 1.673.092 IU/mL and mean F score was: 2.10 ± 1.18 (21% cirrhotic). SVR rate was higher in rs8099917 TT genotypes (55%) when compared to GT/GG (25%) (p = 0.002) and in rs1512979860 CC (64%) than in CT/TT (30%) (p = 0.004). The univariate analysis showed that rs8099917 TT (OR 3.7; 95 %CI 1.5-8.7; p = 0.002), rs12979860 CC (OR 4.6; 95%CI 1.5-13.7; p = 0.006), low viral load (OR 4.6; 95% CI 1.7-12.6; p = 0.002) and F0-2 (OR 8.5; 95% CI 2.3-30.6; p = 0.001) were significantly associated with SVR. In the multivariate analysis, rs12979860 CC, rs8099917 TT, viral load < 400.000 IU/mL and F0-2 were associated with SVR rates (p = 0.029, p = 0.012, p = 0.013 and p = 0.004, respectively). Conclusion. IL28B host genotypes should be added to baseline predictors of response to PR therapy in Latin American patients with European ancestry.

Authors and Affiliations

Ezequiel Ridruejo, Ángela Solano, Sebastián Marciano, Omar Galdame, Raúl Adrover, Daniel Cocozzella, Dreanina Delettieres, Alfredo Martínez, Adrián Gadano, Oscar Mandó, Marcelo Silva

Keywords

Related Articles

The risk of carcinogenesis in congenital choledochal cyst patients: an analysis of 214 cases

Background. Choledochal cysts are most common in Asian populations. In addition, the incidence of biliary tract malignancies from choledochal cysts is increasing, but the risk of carcinogenesis is still unclear. Material...

Meta-analysis of the clinical value of oxymatrine on sustained virological response in chronic hepatitis B

Introduction. Oxymatrine (OMTR) is widely used for the treatment of chronic hepatitis B (CHB) in China. Several recent reportsrevealed that OMTR together with interferon yielded a higher sustained virological response (...

The preventive effect of low molecular weight heparin on CCL4-induced necrosis and apoptosis in rat liv

Introduction. Heparin having anti-inflammatory and anti-fibrotic properties may have therapeutic effect on liver injury. The present study investigated the effect of low molecular weight heparin (Enoxaparin) on carbon te...

Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters

[b]Introduction[/b]. Liver cirrhosis is associated with hyperdynamic circulation which can result in heart failure. Transjugular intrahepatic portosystemic shunt (TIPS) due to increase of cardiac output is a stressful st...

Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis

Lipoprotein X (LpX) is an abnormal lipoprotein associated with cholestasis. It is a significant cause of severe hypercholesterolemia and should always be considered in patients with cholestatic liver disease. This case h...

Download PDF file
  • EP ID EP78075
  • DOI -
  • Views 114
  • Downloads 0

How To Cite

Ezequiel Ridruejo, Ángela Solano, Sebastián Marciano, Omar Galdame, Raúl Adrover, Daniel Cocozzella, Dreanina Delettieres, Alfredo Martínez, Adrián Gadano, Oscar Mandó, Marcelo Silva (2011). Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin. Annals of Hepatology, 10(4), 452-457. https://europub.co.uk/articles/-A-78075